The effect of comorbid illness and functional status on the expected benefits of intensive glucose control in older patients with type 2 diabetes: A decision analysis

University of Chicago, Chicago, Illinois 60637, USA.
Annals of internal medicine (Impact Factor: 17.81). 08/2008; 149(1):11-9.
Source: PubMed


Physicians are uncertain about when to pursue intensive glucose control among older patients with diabetes.
To assess the effect of comorbid illnesses and functional status, mediated through background mortality, on the expected benefits of intensive glucose control.
Decision analysis.
Major clinical studies in diabetes and geriatrics.
Patients 60 to 80 years of age who have type 2 diabetes and varied life expectancies estimated from a mortality index that was validated at the population level.
Patient lifetime. Perspective: Health care system.
Intensive glucose control (hemoglobin A1c [HbA1c] level of 7.0) versus moderate glucose control (HbA1c level of 7.9).
Lifetime differences in incidence of complications and average quality-adjusted days.
Healthy older patients of different age groups had expected benefits of intensive glucose control ranging from 51 to 116 quality-adjusted days. Within each age group, the expected benefits of intensive control steadily declined as the level of comorbid illness and functional impairment increased (mortality index score, 1 to 26 points). For patients 60 to 64 years of age with new-onset diabetes, the benefits declined from 106 days at baseline good health (life expectancy, 14.6 years) to 44 days with 3 additional index points (life expectancy, 9.7 years) and 8 days with 7 additional index points (life expectancy, 4.8 years). A similar decline in benefits occurred among patients with prolonged duration of diabetes.
With alternative model assumptions (such as Framingham models), expected benefits of intensive control declined as mortality index scores increased.
Diabetes clinical trial data were lacking for frail, older patients. The mortality index was not validated for use in predicting individual-level life expectancies. Adverse effects of intensive control were not taken into account.
Among older diabetic patients, the presence of multiple comorbid illnesses or functional impairments is a more important predictor of limited life expectancy and diminishing expected benefits of intensive glucose control than is age alone.

Download full-text


Available from: Harry Zhang, Feb 04, 2015
  • Source
    • "Diabetes mellitus is a chronic degenerative endocrine disease that affects millions of individuals. This disease is associated with a polypathological condition, and its complications progressively affect quality of life and survival (Huang et al. 2008; Eckert 2012). The many complications associated with diabetes include cardiovascular diseases, peripheral neuropathy, retinopathy, chronic renal failure, and impaired mental health (Blaum et al. 2007; Maiorana et al. 2002; Reeves et al. 2010), which put diabetic patients in a polypathological condition (i.e., when diabetes coexists with two or more other diseases, such as hypertension, chronic renal failure , depression, and ischemic heart disease) (Rodríguez- Mañas et al. 2014). "
    [Show abstract] [Hide abstract]
    ABSTRACT: In elderly populations, diabetes is associated with reduced muscle strength, poor muscle quality, and accelerated loss of muscle mass. In addition, diabetes mellitus increases risk for accelerated aging and for the development of frailty syndrome. This disease is also associated with a polypathological condition, and its complications progressively affect quality of life and survival. Exercise interventions, including resistance training, represent the cornerstones of diabetes management, especially in patients at severe functional decline. This review manuscript aimed to describe the beneficial effects of different exercise interventions on the functional capacity of elderly diabetics, including those at polypathological condition. The Scielo, Science Citation Index, MEDLINE, Scopus, Sport Discus and ScienceDirect databases were searched from 1980 to 2015 for articles published from original scientific investigations. In addition to the beneficial effects of exercise interventions on glycemic control, and on the cardiovascular risk factors associated with diabetes, physical exercise is an effective intervention to improve muscle strength, power output, and aerobic power and functional capacity in elderly diabetic patients. Thus, a combination of resistance and endurance training is the most effective exercise intervention to promote overall physical fitness in these patients. In addition, in diabetic patients with frailty and severe functional decline, a multicomponent exercise program including strength and power training, balance exercises and gait retraining may be an effective intervention to reduce falls, improve functional capacity and quality of life in these patients.
    Age 05/2015; DOI:10.1007/s11357-015-9800-2 · 3.45 Impact Factor
  • Source
    • "In a cross-sectional analysis of 3075 well-functioning older adults aged 70-79 [1], poor glycemic control was associated with risk of early functional decline in individuals with diabetes. Recent research based on UKPDS (United Kingdom Prospective Diabetes Study) risk models further demonstrate that the presence of functional impairments may diminish the benefits of achieving intensive glucose control [22]. Among older adults with diabetes, prior research suggests that an association exists between hyperglycemia and frailty, muscle weakness, and poor muscle quality [23,24]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Diabetes is associated with an increased risk of functional decline in older adults. Few studies have investigated the contribution of functional decline to excess mortality risk in older people with diabetes. The aim of this study was to examine how diabetes in combination with different levels of functional decline affects 7-year mortality in older adults. We analyzed data from a nationally representative sample of people aged 65 years and over, participating in the 2001 National Health Interview Survey in Taiwan. A total of 1873 participants were followed through 2002-2008, of whom 286 (15.3%) had a history of diabetes confirmed by a medical professional. Participants were divided into three functional status groups: (1) high functioning-no limitations involving activities of daily living (ADLs), instrumental activities of daily living (IADLs), or physical functioning; (2) low functioning-limitations in one or more ADLs; (3) middle functioning-all participants in between groups 1 and 2. The crude mortality rate was 52.7 per 1,000 person-years in those with diabetes and 34.1 per 1,000 person-years in those without diabetes. After adjustment for other factors, diabetes alone was not associated with an increased mortality risk in those with high functioning. However, diabetes alone had a hazard ratio (HR) for mortality of 1.90 (95%CI = [1.02-3.53]) in those with middle functioning and 3.67 (95%CI = [1.55-8.69]) in those with low functioning. The presence of diabetes and one or more other chronic conditions was associated with a HR for mortality of 2.46 (95%CI = [1.61-3.77]) in those with middle functioning and 4.03 (95%CI = [2.31-7.03]) in those with low functioning. Our results indicate that diabetes is not associated with increased mortality in those with high functioning. There was a gradient effect of functional decline on mortality in individuals with diabetes. Additionally, among participants with other chronic conditions, functional decline was associated with a greater burden of mortality in older adults with diabetes. These findings highlight the critical importance of the prevention of cardiovascular disease morbidity and the maintenance of functional abilities in order to reduce mortality risk in older adults with diabetes.
    BMC Public Health 12/2011; 11(1):953. DOI:10.1186/1471-2458-11-953 · 2.26 Impact Factor
  • Source
    • "Intensive glycemic control may reduce risk of diabetes microvascular complications but its effect on cardiovascular outcomes is more controversial. A decision analysis showed that, among older patients with diabetes, the presence of multiple comorbid illnesses or functional impairments was an important predictor of diminishing expected benefits of intensive glycemic control [23]. These results were confirmed in a recent study that showed that patients with high levels of comorbidity received diminished cardiovascular benefit from intensive glycemic control [24]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: This study assessed whether the number of comorbid conditions unrelated to diabetes was associated with a delay in therapeutic progression of diabetes treatment in Australian veterans. A retrospective cohort study was undertaken using data from the Australian Department of Veterans' Affairs (DVA) claims database between July 2000 and June 2008. The study included new users of metformin or sulfonylurea medicines. The outcome was the time to addition or switch to another antidiabetic treatment. The total number of comorbid conditions unrelated to diabetes was identified using the pharmaceutical-based comorbidity index, Rx-Risk-V. Competing risk regression analyses were conducted, with adjustments for a number of covariates that included age, gender, residential status, use of endocrinology service, number of hospitalisation episodes and adherence to diabetes medicines. Overall, 20,134 veterans were included in the study. At one year, 23.5% of patients with diabetes had a second medicine added or had switched to another medicine, with 41.4% progressing by 4 years. The number of unrelated comorbidities was significantly associated with the time to addition of an antidiabetic medicine or switch to insulin (subhazard ratio [SHR] 0.87 [95% CI 0.84-0.91], P<0.001). Depression, cancer, chronic obstructive pulmonary disease, dementia, and Parkinson's disease were individually associated with a decreased likelihood of therapeutic progression. Age, residential status, number of hospitalisations and adherence to anti-diabetic medicines delayed therapeutic progression. Increasing numbers of unrelated conditions decreased the likelihood of therapeutic progression in veterans with diabetes. These results have implications for the development of quality measures, clinical guidelines and the construction of models of care for management of diabetes in elderly people with comorbidities.
    PLoS ONE 11/2010; 5(11):e14024. DOI:10.1371/journal.pone.0014024 · 3.23 Impact Factor
Show more